InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,019.61
(
1.33%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bocxman

Send PM Follow Ignore
Followers 2
Posts 1054
Boards Moderated 0
Alias Born 03/03/2005

bocxman

Re: twelvebees post# 3879

Thursday, 05/25/2006 7:55:15 PM

Thursday, May 25, 2006 7:55:15 PM

Post# of 30387
twelvebees...that is all very naive thinking (no offense). re exclusive license, if ABT announced anything like what you're describing it would make the price tag for an exclusive license go through the roof -- so i think you have the logic backwards on that point. regarding biocurex funding for their research, per the agreement BOCX is not expected to pay for any R&D, marketing, distribution, etc -- so i don't see your point on that one either.

my previous answer does not imply that ABT is trying to "exploit" BOCX...i'm just saying that ABT has ZERO interest in BOCX shareholders. ZERO.

ABT cares about ABT shareholders.



DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up